The number and volume of emergent ischemic lesions following carotid artery stenting may be reduced with use of ticagrelor vs clopidogrel, secondary findings of the PRECISE-MRI trial suggest.
Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization.
Incorporating the Canadian TIA Risk Score into TIA/minor stroke management recommendations can help nonspecialists assess the need for urgent specialty consultation and treatment, researchers say.